 | Up a level |
Leone, Jose P; Cole, Bernard F; Regan, Meredith M; Thürlimann, Beat; Coates, Alan S; Rabaglio, Manuela; Giobbie-Hurder, Anita; Gelber, Richard D; Ejlertsen, Bent; Harvey, Vernon J; Neven, Patrick; Láng, Istvan; Bonnefoi, Herve; Wardley, Andrew; Goldhirsch, Aron; Di Leo, Angelo; Colleoni, Marco; Vaz-Luis, Ines; Lin, Nancy U (2021). Clinical behavior of recurrent hormone receptor-positive breast cancer by adjuvant endocrine therapy within the Breast International Group 1-98 clinical trial. Cancer, 127(5), pp. 700-708. Wiley 10.1002/cncr.33318
Zimmermann, Bettina M; Fanderl, Julia; Koné, Insa; Rabaglio, Manuela; Bürki, Nicole; Shaw, David; Elger, Bernice (2021). Examining information-seeking behavior in genetic testing for cancer predisposition: A qualitative interview study. Patient education and counseling, 104(2), pp. 257-264. Elsevier Ireland 10.1016/j.pec.2020.09.019
Rabaglio, Manuela; Sun, Zhuoxin; Maibach, Rudolf; Giobbie-Hurder, Anita; Ejlertsen, Bent; Harvey, Vernon J; Neven, Patrick; Láng, István; Bonnefoi, Hervé; Wardley, Andrew; Ruepp, Barbara; Castiglione, Monica; Coates, Alan S; Gelber, Richard D; Goldhirsch, Aron; Colleoni, Marco; Thürlimann, Beat; Regan, Meredith M (2020). Cumulative incidence of cardiovascular events under tamoxifen and letrozole alone and in sequence: a report from the BIG 1-98 trial. Breast cancer research and treatment, 185(3), pp. 697-707. Springer 10.1007/s10549-020-05981-z
Ruggeri, M; Pagan, E; Bagnardi, V; Bianco, N; Gallerani, E; Buser, K; Giordano, M; Gianni, L; Rabaglio, Manuela; Freschi, A; Cretella, E; Clerico, M; Farolfi, A; Simoncini, E; Ciccarese, M; Rauch, D; Ramello, M; Glaus, A; Berardi, R; Pellanda, A Franzetti; ... (2019). Fertility concerns, preservation strategies and quality of life in young women with breast cancer: Baseline results from an ongoing prospective cohort study in selected European Centers. The breast, 47, pp. 85-92. Elsevier 10.1016/j.breast.2019.07.001
Peters, S; Felip, E; Dafni, U; Belka, C; Guckenberger, M; Irigoyen, A; Nadal, E; Becker, Antje; Vees, H; Pless, M; Martinez-Marti, A; Tufman, A; Lambrecht, M; Andratschke, N; Piguet, A C; Kassapian, M; Roschitzki-Voser, H; Rabaglio, Manuela; Stahel, R A; Vansteenkiste, J; ... (2019). Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-radiotherapy regimen in stage III non-small cell lung cancer-The ETOP NICOLAS trial. Lung cancer, 133, pp. 83-87. Elsevier 10.1016/j.lungcan.2019.05.001
Dziadziuszko, Rafal; Smit, Egbert F; Dafni, Urania; Wolf, Juergen; Wasąg, Bartosz; Biernat, Wojciech; Finn, Stephen P; Kammler, Roswitha; Tsourti, Zoi; Rabaglio, Manuela; Ruepp, Barbara; Roschitzki-Voser, Heidi; Stahel, Rolf A; Felip, Enriqueta; Peters, Solange (2019). Afatinib in NSCLC With HER2 Mutations: Results of the Prospective, Open-Label Phase II NICHE Trial of European Thoracic Oncology Platform (ETOP). Journal of thoracic oncology, 14(6), pp. 1086-1094. Elsevier 10.1016/j.jtho.2019.02.017
Ribi, Karin; Luo, Weixiu; Colleoni, Marco; Karlsson, Per; Chirgwin, Jacquie; Aebi, Stefan; Jerusalem, Guy; Neven, Patrick; Di Lauro, Vincenzo; Gomez, Henry L; Ruhstaller, Thomas; Abdi, Ehtesham; Biganzoli, Laura; Müller, Bettina; Barbeaux, Annelore; Graas, Marie-Pascale; Rabaglio, Manuela; Francis, Prudence A; Foukakis, Theodoros; Pagani, Olivia; ... (2019). Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial. British journal of cancer, 120(10), pp. 959-967. Springer Nature 10.1038/s41416-019-0435-4
Loi, Sherene; Giobbie-Hurder, Anita; Gombos, Andrea; Bachelot, Thomas; Hui, Rina; Curigliano, Giuseppe; Campone, Mario; Biganzoli, Laura; Bonnefoi, Hervé; Jerusalem, Guy; Bartsch, Rupert; Rabaglio, Manuela-Poretti; Kammler, Roswitha; Maibach, Rudolf; Smyth, Mark J; Di Leo, Angelo; Colleoni, Marco; Viale, Giuseppe; Regan, Meredith M and André, Fabrice (2019). Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b-2 trial. The lancet oncology, 20(3), pp. 371-382. Elsevier 10.1016/S1470-2045(18)30812-X
Dellapasqua, Silvia; Gray, Kathryn P.; Munzone, Elisabetta; Rubino, Daniela; Gianni, Lorenzo; Johansson, Harriet; Viale, Giuseppe; Ribi, Karin; Bernhard, Jürg; Kammler, Roswitha; Maibach, Rudolf; Rabaglio, Manuela; Ruepp, Barbara; Di Leo, Angelo; Coates, Alan S.; Gelber, Richard D.; Regan, Meredith M.; Goldhirsch, Aron; Colleoni, Marco (2019). Neoadjuvant Degarelix Versus Triptorelin in Premenopausal Patients Who Receive Letrozole for Locally Advanced Endocrine-Responsive Breast Cancer: A Randomized Phase II Trial. Journal of clinical oncology, 37(5), pp. 386-395. American Society of Clinical Oncology 10.1200/JCO.18.00296
Pimentel, Isabel; Chen, Bingshu E.; Lohmann, Ana Elisa; Ennis, Marguerite; Ligibel, Jennifer A.; Shepherd, Lois E.; Hershman, Dawn L.; Stambolic, Vuk; Mayer, Ingrid A.; Hobday, Timothy J.; Lemieux, Julie; Thompson, Alastair Mark; Rastogi, Priya; Gelmon, Karen A.; Whelan, Timothy Joseph; Rabaglio-Poretti, Manuela; Dowling, Ryan JO; Parulekar, Wendy R.; Goodwin, Pamela Jean (2019). The effect of metformin on sex hormones in non-diabetic breast cancer patients in CCTG MA.32: A Phase III randomized adjuvant trial of metformin versus placebo in addition to standard therapy. Journal of clinical oncology, 37(15_suppl), p. 529. American Society of Clinical Oncology 10.1200/JCO.2019.37.15_suppl.529
Francis, PA; Pagani, O; Fleming, GF; Walley, BA; Colleoni, M; Láng, I; Gómez, HL; Tondini, C; Ciruelos, E; Burstein, HJ; Bonnefoi, HR; Bellet, M; Martino, S; Geyer, Jr. CE; Goetz, MP; Stearns, V; Pinotti, G; Puglisi, F; Spazzapan, S; Climent, MA; ... (2018). Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer. New England journal of medicine NEJM, 379(2), pp. 122-137. Massachusetts Medical Society MMS 10.1056/NEJMoa1803164
Gennari, A; Sun, Z; Hasler-Strub, U; Colleoni, M; Kennedy, M J; Von Moos, R; Cortés, J; Vidal, M J; Hennessy, B; Walshe, J; Amillano Parraga, K; Ribi, K; Bernhard, Jürg; Morales, S Murillo; Pagani, O; Barbeaux, A; Borstnar, S; Rabaglio, Manuela; Maibach, R; Regan, M M; ... (2018). A randomized phase II study evaluating different maintenance schedules of nab-Paclitaxel in the first-line treatment of metastatic breast cancer: final results of the IBCSG 42-12/BIG 2-12 SNAP trial. Annals of oncology, 29(3), pp. 661-668. Oxford University Press 10.1093/annonc/mdx772
Colleoni, Marco; Luo, Weixiu; Karlsson, Per; Chirgwin, Jacquie; Aebi, Stefan; Jerusalem, Guy; Neven, Patrick; Hitre, Erika; Graas, Marie-Pascale; Simoncini, Edda; Kamby, Claus; Thompson, Alastair; Loibl, Sibylle; Gavilá, Joaquín; Kuroi, Katsumasa; Marth, Christian; Müller, Bettina; O'Reilly, Seamus; Di Lauro, Vincenzo; Gombos, Andrea; ... (2018). Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial. Lancet oncology, 19(1), pp. 127-138. Elsevier 10.1016/S1470-2045(17)30715-5
Strasser-Weippl, Kathrin; Higgins, Michaela J; Chapman, Judith-Anne; Ingle, James; Sledge, George W; Budd, George T; Ellis, Matthew; Pritchard, Kathleen; Clemons, Mark J; Badovinac-Crnjevic, Tanja; Han, Lei; Gelmon, Karen A; Rabaglio, Manuela; Elliott, Catherine; Shepherd, Lois; Goss, Paul E (2018). Effects of Celecoxib and Low-dose Aspirin on Outcomes in Adjuvant Aromatase Inhibitor-Treated Patients: CCTG MA.27. Journal of the National Cancer Institute JNCI, 110(9), pp. 1003-1008. Oxford University Press 10.1093/jnci/djy017
Nikolaidis, Christos; Ming, Chang; Pedrazzani, Carla; van der Horst, Tina; Kaiser-Grolimund, Andrea; Ademi, Zanfina; Bührer-Landolt, Rosmarie; Bürki, Nicole; Caiata-Zufferey, Maria; Champion, Victoria; Chappuis, Pierre O; Kohler, Carmen; Erlanger, Tobias E; Graffeo, Rossella; Hampel, Heather; Heinimann, Karl; Heinzelmann-Schwarz, Viola; Kurzeder, Christian; Monnerat, Christian; Northouse, Laurel L; ... (2018). Challenges and Opportunities for Cancer Predisposition Cascade Screening for Hereditary Breast and Ovarian Cancer and Lynch Syndrome in Switzerland: Findings from an International Workshop. Public health genomics, 21(3-4), pp. 121-132. Karger 10.1159/000496495
Katapodi, Maria C; Viassolo, Valeria; Caiata-Zufferey, Maria; Nikolaidis, Christos; Bührer-Landolt, Rosmarie; Buerki, Nicole; Graffeo, Rossella; Horvath, Henrik Csaba; Kurzeder, Christian; Rabaglio, Manuela; Scharfe, Michael; Urech, Corinne; Erlanger, Tobias E; Probst-Hensch, Nicole; Heinimann, Karl; Heinzelmann-Schwarz, Viola; Pagani, Olivia; Chappuis, Pierre O (2017). Cancer Predisposition Cascade Screening for Hereditary Breast/Ovarian Cancer and Lynch Syndromes in Switzerland: Study Protocol. JMIR research protocols, 6(9), e184. JMIR Publications 10.2196/resprot.8138
Lipton, Allan; Chapman, Judith-Anne W; Leitzel, Kim; Garg, Ashwani; Pritchard, Kathleen I; Ingle, James N; Budd, G Thomas; Ellis, Matthew J; Sledge, George W; Rabaglio, Manuela; Han, Lei; Elliott, Catherine R; Shepherd, Lois E; Goss, Paul E; Ali, Suhail M (2017). Osteoporosis therapy and outcomes for postmenopausal patients with hormone receptor-positive breast cancer: NCIC CTG MA.27. Cancer, 123(13), pp. 2444-2451. John Wiley & Sons 10.1002/cncr.30682
Rosell, Rafael; Dafni, Urania; Felip, E; Curioni-Fontecedro, A; Gautschi, O; Peters, S; Massuti, B; Palmero, R; Aix, SP; Carcereny, E; Früh, M; Pless, M; Popat, S; Kotsakis, A; Cuffe, S; Bidoli, P; Favaretto, A; Froesch, P; Reguart, N; Puente, J; ... (2017). Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial. The lancet. Respiratory medicine, 5(5), pp. 435-444. Elsevier 10.1016/S2213-2600(17)30129-7
Borgquist, Signe; Giobbie-Hurder, Anita; Ahern, Thomas P; Garber, Judy E; Colleoni, Marco; Láng, István; Debled, Marc; Ejlertsen, Bent; von Moos, Roger; Smith, Ian; Coates, Alan S; Goldhirsch, Aron; Rabaglio, Manuela; Price, Karen N; Gelber, Richard D; Regan, Meredith M; Thürlimann, Beat (2017). Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 Study. Journal of clinical oncology, 35(11), pp. 1179-1188. American Society of Clinical Oncology 10.1200/JCO.2016.70.3116
Pagani, O; Klingbiel, D; Ruhstaller, T; Nolè, F; Eppenberger, S; Oehlschlegel, C; Bernhard, Jürg; Brauchli, P; Hess, D; Mamot, C; Munzone, E; Pestalozzi, B; Rabaglio, Manuela; Aebi, S; Ribi, K; Rochlitz, C; Rothgiesser, K; Thürlimann, B; von Moos, R; Zaman, K; ... (2017). Do all patients with advanced HER2 positive breast cancer need upfront-chemo when receiving trastuzumab? Randomized phase III trial SAKK 22/99. Annals of oncology, 28(2), pp. 305-312. Oxford University Press 10.1093/annonc/mdw622
Johansson, Harriet; Gray, Kathryn P; Pagani, Olivia; Regan, Meredith M; Viale, Giuseppe; Aristarco, Valentina; Macis, Debora; Puccio, Antonella; Roux, Susanne; Maibach, Rudolf; Colleoni, Marco; Rabaglio, Manuela; Price, Karen N; Coates, Alan S; Gelber, Richard D; Goldhirsch, Aron; Kammler, Roswitha; Bonanni, Bernardo; Walley, Barbara A (2016). Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial. Breast cancer research, 18(1), p. 110. BioMed Central Ltd. 10.1186/s13058-016-0771-8
Chirgwin, Jacquie H; Giobbie-Hurder, Anita; Coates, Alan S; Price, Karen N; Ejlertsen, Bent; Debled, Marc; Gelber, Richard D; Goldhirsch, Aron; Smith, Ian; Rabaglio, Manuela; Forbes, John F; Neven, Patrick; Láng, István; Colleoni, Marco; Thürlimann, Beat (2016). Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence. Journal of clinical oncology, 34(21), pp. 2452-2459. American Society of Clinical Oncology 10.1200/JCO.2015.63.8619
Francis, Prudence A; Regan, Meredith M; Fleming, Gini F; Láng, István; Ciruelos, Eva; Bellet, Meritxell; Bonnefoi, Hervé R; Climent, Miguel A; Da Prada, Gian Antonio; Burstein, Harold J; Martino, Silvana; Davidson, Nancy E; Geyer, Charles E; Walley, Barbara A; Coleman, Robert; Kerbrat, Pierre; Buchholz, Stefan; Ingle, James N; Winer, Eric P; Rabaglio, Manuela; ... (2015). Adjuvant ovarian suppression in premenopausal breast cancer. New England journal of medicine NEJM, 372(5), pp. 436-446. Massachusetts Medical Society MMS 10.1056/NEJMoa1412379
Huober, J.; Cole, B. F.; Rabaglio, Manuela; Giobbie-Hurder, A.; Wu, J.; Ejlertsen, B.; Bonnefoi, H.; Forbes, J. F.; Neven, P.; Láng, I.; Smith, I.; Wardley, A.; Price, K. N.; Goldhirsch, A.; Coates, A. S.; Colleoni, M.; Gelber, R. D.; Thürlimann, B. (2014). Symptoms of endocrine treatment and outcome in the BIG 1-98 study. Breast cancer research and treatment, 143(1), pp. 159-169. Springer 10.1007/s10549-013-2792-7
Regan, Meredith M; Pagani, Olivia; Fleming, Gini F; Walley, Barbara A; Price, Karen N; Rabaglio, Manuela; Maibach, Rudolf; Ruepp, Barbara; Coates, Alan S; Goldhirsch, Aron; Colleoni, Marco; Gelber, Richard D; Francis, Prudence A (2013). Adjuvant treatment of premenopausal women with endocrine-responsive early breast cancer: design of the TEXT and SOFT trials. Breast, 22(6), pp. 1094-1100. Elsevier 10.1016/j.breast.2013.08.009
Crivellari, Diana; Gray, Kathryn P.; Dellapasqua, Silvia; Puglisi, Fabio; Ribi, Karin; Price, Karen N.; Láng, István; Gianni, Lorenzo; Spazzapan, Simon; Pinotti, Graziella; Lüthi, Jean-Marc; Gelber, Richard D.; Regan, Meredith M; Colleoni, Marco; Castiglione-Gertsch, Monica; Maibach, Rudolf; Rabaglio, Manuela; Coates, Alan S.; Goldhirsch, Aron (2013). Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a "standard chemotherapy regimen": the CASA randomized trial. Breast, 22(2), pp. 130-137. Elsevier 10.1016/j.breast.2013.01.015
Goss, Paul E.; Ingle, James N.; Pritchard, Kathleen I.; Ellis, Matthew J.; Sledge, George W.; Budd, G. Thomas; Rabaglio, Manuela; Ansari, Rafat H.; Johnson, David B.; Tozer, Richard; D'Souza, David P.; Chalchal, Haji; Spadafora, Silvana; Stearns, Vered; Perez, Edith A.; Liedke, Pedro E. R.; Lang, Istvan; Elliott, Catherine; Gelmon, Karen A.; Chapman, Judy-Anne W.; ... (2013). Exemestane Versus Anastrozole in Postmenopausal Women With Early Breast Cancer: NCIC CTG MA.27—A Randomized Controlled Phase III Trial. Journal of clinical oncology, 31(11), pp. 1398-1404. American Society of Clinical Oncology 10.1200/JCO.2012.44.7805
Ewertz, Marianne; Gray, Kathryn P; Regan, Meredith M; Ejlertsen, Bent; Price, Karen N; Thürlimann, Beat; Bonnefoi, Hervé; Forbes, John F; Paridaens, Robert J; Rabaglio, Manuela; Gelber, Richard D; Colleoni, Marco; Láng, István; Smith, Ian E; Coates, Alan S; Goldhirsch, Aron; Mouridsen, Henning T (2012). Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trial. Journal of clinical oncology, 30(32), pp. 3967-75. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2011.40.8666
Regan, Meredith M; Neven, Patrick; Giobbie-Hurder, Anita; Goldhirsch, Aron; Ejlertsen, Bent; Mauriac, Louis; Forbes, John F; Smith, Ian; Láng, István; Wardley, Andrew; Rabaglio, Manuela; Price, Karen N; Gelber, Richard D; Coates, Alan S; Thürlimann, Beat; BIG 1-98 Collaborative Group, ; International Breast Cancer Study Group (IBCSG), (2011). Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up. Lancet oncology, 12(12), pp. 1101-8. Oxford: Elsevier 10.1016/S1470-2045(11)70270-4
Karlsson, P; Sun, Z; Braun, D; Price, K N; Castiglione-Gertsch, M; Rabaglio, M; Gelber, R D; Crivellari, D; Collins, J; Murray, E; Zaman, K; Colleoni, M; Gusterson, B A; Viale, G; Regan, M M; Coates, A S; Goldhirsch, A (2011). Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer. Annals of oncology, 22(10), pp. 2216-26. Oxford: Oxford University Press 10.1093/annonc/mdq735
Aebi, S; Sun, Z; Braun, D; Price, K N; Castiglione-Gertsch, M; Rabaglio, M; Gelber, R D; Crivellari, D; Lindtner, J; Snyder, R; Karlsson, P; Simoncini, E; Gusterson, B A; Viale, G; Regan, M M; Coates, A S; Goldhirsch, A (2011). Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: long-term follow up on IBCSG Trial IX. Annals of oncology, 22(9), pp. 1981-7. Oxford: Oxford University Press 10.1093/annonc/mdq754
Rabaglio, Manuela; Ruepp, Barbara (2010). Death due to liver failure during endocrine therapy for premenopausal breast cancer. Acta oncologica, 49(6), pp. 874-6. Stockholm: Acta Oncologica 10.3109/0284186X.2010.484813
Rabaglio, M; Sun, Z; Price, K N; Castiglione-Gertsch, M; Hawle, H; Thürlimann, B; Mouridsen, H; Campone, M; Forbes, J F; Paridaens, R J; Colleoni, M; Pienkowski, T; Nogaret, J-M; Láng, I; Smith, I; Gelber, R D; Goldhirsch, A; Coates, A S (2009). Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial. Annals of oncology, 20(9), pp. 1489-98. Oxford: Oxford University Press 10.1093/annonc/mdp033
Crivellari, Diana; Sun, Zhuoxin; Coates, Alan S; Price, Karen N; Thürlimann, Beat; Mouridsen, Henning; Mauriac, Louis; Forbes, John F; Paridaens, Robert J; Castiglione-Gertsch, Monica; Gelber, Richard D; Colleoni, Marco; Láng, István; Del Mastro, Lucia; Gladieff, Laurence; Rabaglio, Manuela; Smith, Ian E; Chirgwin, Jacquie H; Goldhirsch, Aron (2008). Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: the BIG 1-98 trial. Journal of clinical oncology, 26(12), pp. 1972-9. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2007.14.0459
Eicher, M; Rabaglio, M (2008). Kinderwunsch und Krebs: Wie kann Bedürfnissen betroffener Frauen und deren Partner begegnet werden? Hämato-onkologische Nachrichten(12) Köln: Biermann
Rabaglio, Manuela; Aebi, Stefan; Castiglione-Gertsch, Monica (2007). Controversies of adjuvant endocrine treatment for breast cancer and recommendations of the 2007 St Gallen conference. Lancet oncology, 8(10), pp. 940-9. Oxford: Elsevier 10.1016/S1470-2045(07)70317-0
Mouridsen, Henning; Keshaviah, Aparna; Coates, Alan S; Rabaglio, Manuela; Castiglione-Gertsch, Monica; Sun, Zhuoxin; Thürlimann, Beat; Mauriac, Louis; Forbes, John F; Paridaens, Robert; Gelber, Richard D; Colleoni, Marco; Smith, Ian; Price, Karen N; Goldhirsch, Aron (2007). Cardiovascular adverse events during adjuvant endocrine therapy for early breast cancer using letrozole or tamoxifen: safety analysis of BIG 1-98 trial. Journal of clinical oncology, 25(36), pp. 5715-22. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2007.12.1665
Mauriac, L; Keshaviah, A; Debled, M; Mouridsen, H; Forbes, JF; Thürlimann, B; Paridaens, R; Monnier, A; Láng, I; Wardley, A; Nogaret, JM; Gelber, RD; Castiglione-Gertsch, M; Price, KN; Coates, AS; Smith, I; Viale, G; Rabaglio, M; Zabaznyi, N; Goldhirsch, A; ... (2007). Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial. Annals of oncology, 18(5), pp. 859-67. Oxford: Oxford University Press 10.1093/annonc/mdm001
